Amyloid β-peptide and the dementia of Parkinson's disease

Movement Disorders

Volumn 11, Issue 6, 1996, Pages 647-653

  Jendroska, Klaus ^a   Lees, Andrew J ^b   Poewe, Werner ^c   Daniel, Susan E ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c University Department of Neurology   (Austria)

Author keywords

Amyloid; Alzheimer's disease; Dementia; Lewy body; Neuro fibrillary tangle; Parkinson's disease

Indexed keywords

AMYLOID BETA PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEMENTIA; HUMAN; HUMAN TISSUE; HYDROCEPHALUS; LEWY BODY; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PATHOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BRAIN; CEREBRAL CORTEX; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEWY BODIES; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PARKINSON DISEASE; REFERENCE VALUES;

EID: 0029800578     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110609     Document Type: Article

References (33)

1. Gibb WRG. Dementia and Parkinson's disease. Br J Psychiatry 1989;154:596-614.
2. Alvord E, Forno LS, Kusske JA. The pathology of parkinsonism: a comparison of degeneration in cerebral cortex and brainstem. Adv Neurol 1974;5:175-193.
3. Hakim AM, Mathieson G. Dementia in Parkinson's disease: a neuropathological study. Neurology 1979;29:1209-1214.
4. Boller F, Mitzutani T, Roessman U, Gambetti P. Parkinson disease, dementia and Alzheimer disease: clinicopathological correlations. Ann Neurol 1980;7:329-335.
5. Leverenz S, Sumi SM. Parkinson's disease in patients with Alzheimer's disease. Arch Neurol 1986;43:662-664.
6. Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987;37:754-760.
7. Taraboulos A, Jendroska K, Serban D, Yang SL, DeArmond SJ, Prusiner SB. Regional mapping of prion proteins in brain. Proc Natl Acad Sci USA 1992;89:7620-7624.
8. Jendroska K, Poewe W, Daniel SE, et al. Ischemic stress induces deposition of amyloid β-immunoreactivity in human brain. Ada Neuropathol 1995;5:461-466.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed., revised. Washington, DC: American Psychiatric Association, 1987.
10. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-259.
11. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991;41:479-486.
12. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
13. Braak H, Braak E. Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles and neuropil threads in the cerebral cortex. J Neural Transm 1990;2:45-57.
14. Brown RG, Marsden CD. How common is dementia in Parkinson's disease? Lancet 1984;ii:1262-1265.
15. Lees AJ. Parkinson's disease and dementia. Lancet 1985;i: 43-44.
16. Gibb WRG, Lees AJ. A comparison of clinical and pathological features of young and old-onset Parkinson's disease. Neurology 1988;38:1402-1406.
17. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia. Arch Neurol 1992;49:492-497.
18. Jorm AF, Henderson AM, Jacomb PA. Projected increases in the number of dementia cases for 29 developed countries: application of a new method for making projections. Acta Psychiatr Scand 1988;78:493-500.
19. Mann DMA, Brown A, Prinja D, et al. An analysis of the morphology of senile plaques in Down's syndrome patients of different ages using immunocytochemical and lectin histochemical techniques. Neuropathol Appl Neurobiol 1989; 15:317-329.
20. Quinn NP, Rossor MN, Marsden CD. Dementia and Parkinson's disease - pathological and neurochemical considerations. Br Med Bull 1986;42:86-90.
21. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 1989;245:417-420.
22. Flood JF, Roberts E, Sherman MA, Kaplan BE, Morley JE. Topography of a binding site for small amnestic peptides deduced from structure-activity studies: relation to amnestic effect of amyloid β protein. Proc Natl Acad Sci USA 1994; 91:380-384.
23. Dickson DW, Singer G, Davies P, Yen SH, Crystal HA. Regional immunocytochemical studies of brains of prospectively studied demented and nondemented normal elderly humans. In: Nicolini M, Zatta PF, Corain B, eds. Alzheimer's disease and related disorders, advances in the biosciences. Vol 87. Oxford: Pergamon Press, 1993:123-126.
24. Okazaki H, Lipkin LE, Aronson SM. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961;20:237-244.
25. Kosaka K, Shibayama H, Kobayashi H, Hoshinot T, Iwase S. An autopsy case of unclassifiable presenile dementia. Psychiatr Neurol Jpn 1973;75:18-34.
26. Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990;237:197-204.
27. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989;52:1236-1247.
28. Rossor MN, Newman S, Frackowiak RS, Lantos P, Kennedy AM. Alzheimer's disease families with amyloid precursor protein mutations. Ann NY Acad Sci 1993;695: 198-202.
29. Lantos PL, Ovenstone IMK, Johnson J, Clelland CA, Roques P, Rossor MN. Lewy bodies in the brain of two members of a family with the 717 (Val to Ile) mutation of the amyloid precursor protein gene. Neurosci Lett 1994;172:77-80.
30. Gaspar P, Gray F. Dementia in idiopathic Parkinson's disease: a neuropathological study of 32 cases. Acta Neuropathol 1984;64:43-52.
31. Tagliavini F, Pilleri G, Bouras C, Constantinidis J. The basal nucleus of Meynert in idiopathic Parkinson's disease. Acta Neurol Scand 1984;69:20-28.
32. Paulus W, Jellinger K. The neuropathological basis of different clinical subgroups of Parkinson's disease. J Neuropathol Exp Neurol 1991;50:743-755.
33. Duyckaerts C, Gaspar P, Costa C, Hauww JJ. Dementia in Parkinson's disease: morphometric data. Adv Neurol 1993; 60:442-455.